Bone Morphogenetic Protein 5 (BMP5) (Middle Region) Peptide
BMP5
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN8095608
$145.08
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 2 to 4 Business Days
Quick Overview for Bone Morphogenetic Protein 5 (BMP5) (Middle Region) Peptide (ABIN8095608)
Target
BMP5
(Bone Morphogenetic Protein 5 (BMP5))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Purpose
- BMP5 Peptide - middle region
-
Sequence
- QGPQSKQPFM VAFFKASEVL LRSVRAANKR KNQNRNKSSS HQDSSRMSSV
-
-
Bone Morphogenetic Protein 5 (BMP5) (AA 317-454) peptide
BMP5 Reactivity: Human Host: Escherichia coli (E. coli) SDS
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- BMP5 (Bone Morphogenetic Protein 5 (BMP5))
-
Background
- This gene encodes a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily. The superfamily includes large families of growth and differentiation factors. Bone morphogenetic proteins were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. These proteins are synthesized as prepropeptides, cleaved, and then processed into dimeric proteins. This protein may act as an important signaling molecule within the trabecular meshwork and optic nerve head, and may play a potential role in glaucoma pathogenesis. This gene is differentially regulated during the formation of various tumors.
-
Molecular Weight
- 52 kDa
-
Gene ID
- 653
-
NCBI Accession
- NP_066551
-
UniProt
- P22003
Target
-
You are here:
